Survey details the high cost of IBS. (Limits Activities).
Mugdha Gore, Ph.D., of Philadelphia reported that in her study population of patients with irritable bowel syndrome (IBS), each had spent an average of $258 for the GI disorder in the past 3 months. And 81% of patients were on at least three therapies: one prescription, one OTC, and one alternative.
In a study conducted for Novartis Pharmaceuticals, she mailed a detailed questionnaire regarding the impact of IBS to 1,340 members of the Intestinal Disease Foundation, a national patient advocacy group.
The response rate was 49%. Overall, 65% of the respondents had IBS by Rome II criteria.
Among employed LBS patients, 39% said their GI disorder caused them to miss work during the past 3 months. They averaged 6 missed days during that period and attributed an additional 16 days of decreased work productivity to their IBS.
Also, 90% of the respondents indicated that LBS limited their ability to perform important daily activities.
|Printer friendly Cite/link Email Feedback|
|Publication:||OB GYN News|
|Date:||Dec 15, 2002|
|Previous Article:||NSAID, aspirin use linked to lower incidence of Alzheimer's. (Taken for 2 Years or More).|
|Next Article:||Line of injectable drugs recalled due to possible contamination. (Made by Urgent Care Pharmacy).|
|Surveys detail high cost of irritable bowel. (More Doctor Visits, Missed Work).|
|Two surveys stress high costs of IBS. (Frequent Office Visits).|
|Familial aggregation of IBS.|